Zydus Lifesciences (ZYDUSLIFE.NS) Financial Analysis & Valuation | Quarter Chart

Zydus Lifesciences (ZYDUSLIFE.NS)

ZYDUSLIFE.NS
Price: $11.75
Fair Value: 🔒
🔒score
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments. It offer... more
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution... more
Description Shares
Market Cap$11.83BExchangeNSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOPunit Patel
IPO Date2002-07-01CAGR0.15%
Employees26,921Websitewww.zyduscadila.com
Div. Yield0.72%Payout Ratio0.22%
Buy Back Yield—Total Yield0.72%
ZYDUSLIFE.NS chart loading...
Fundamentals Technicals
Enterprise Value$987.59BP/E Ratio23.12
Forward P/E24.06PEG Ratio2.57
P/S Ratio5.77P/B Ratio5.77
P/CF Ratio165.7P/FCF Ratio1997.57
EPS$0.51EPS Growth 1Y11.38%
EPS Growth 3Y159.05%EPS Growth 5Y133.02%
Revenue Growth 1Y16.81%Gross Margin0.56%
Operating Margin0.29%Profit Margin0.19%
ROE0.2%ROA0.1%
ROCE0.21%Current Ratio1.27
Quick Ratio0.91Cash Ratio0.09
Debt/Equity0.46Interest Coverage17.71
Altman Z Score3.88Piotroski Score3

View Zydus Lifesciences financial charts →